L-Glutathione, NAC, Alpha Lipoic Acid, Vitamin C
L-Glutathione, NAC, Alpha Lipoic Acid, Vitamin C, NPN 80146088: natural health product licensed in Canada. Medicinal ingredients: L-Glutathione, Acide DL-alpha-lipoïque, N-Acétyl-L-cystéine, Vitamine C.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Glutathione Source : Glutathione | 350 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 50 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 200 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 50 mg | 100,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps in collagen formation (to maintain/support healthy bones/cartilage/teeth/(and) gums). Helps in the development and maintenance of bones/cartilage/teeth/(and) gums. Helps in wound healing/(and) connective tissue formation. Helps to maintain/support immune function/the immune system. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding. Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant, breastfeeding or have kidney stones. Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar).
- Contra-Indications
Do not use this product if you are taking antibiotics or nitroglycerin.
Product record
- Licence holder
- Evernate Inc.
- NPN or DIN-HM
- 80146088
- Status
- Active licence
- Licence date
- 12 December 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80146088
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “L-Glutathione, NAC, Alpha Lipoic Acid, Vitamin C (Evernate Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80146088-l-glutathione-nac-alpha-lipoic-acid-vitamin-c, updated 12 December 2025.